Mr David F Jones > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Mr David F Jones
Work Department
Employee Benefits and Executive Compensation
Position
Partner
Career
David F. Jones, co-chair of the employee benefits and executive compensation group, represents both public and private corporations, private equity investors, and hedge funds with respect to qualified and nonqualified retirement plans, as well as executive compensation and employee welfare benefit matters. Mr. Jones has done extensive work in dealing with the employee benefit aspects of mergers and acquisitions, representing both buyers and sellers. In addition, he assists clients with the integration and redesign of their employee benefit programs following significant acquisitions.
Mr. Jones has lectured on employee benefit matters at seminars and conferences sponsored by the Association of Corporate Counsel, the Practising Law Institute, the Pennsylvania-New Jersey-Delaware Employee Benefits Association, and the Strategic Research Institute.
Education
- Temple University, B.B.A., 1979, cum laude
- Temple University Beasley School of Law, J.D., 1982, cum laude, Business Editor of the Temple Law Review
- New York University School of Law, LL.M., 1984, in Taxation
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation